alendronate has been researched along with Acute Lymphoid Leukemia in 6 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bisphosphonate use, in particular pamidronate, improved pain scores, analgesic requirement and musculoskeletal function in patients with osteonecrosis occurring as a complication of childhood ALL therapy." | 5.14 | Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL). ( Carter, T; Cole, C; Kotecha, RS; Lee, SJ; Murray, KJ; Powers, N, 2010) |
| "Osteopenia is a common consequence of the treatment of acute lymphoblastic leukemia (ALL) in children and adolescents, due predominantly to glucocorticosteroid therapy." | 2.73 | Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience. ( Barr, RD; Lethaby, C; Naronha, M; Sala, A; Webber, C; Wiernikowski, J, 2007) |
| "Alendronate therapy was tolerated well." | 2.71 | Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study. ( Atkinson, SA; Barr, RD; Guo, CY; Webber, C; Wiernikowski, JT; Wright, M, 2005) |
| "Low bone mineral density is encountered in children with acute lymphoblastic leukemia (ALL) before, during, and after treatment." | 1.91 | Safety and Efficacy of Alendronate to Treat Osteopenia in Children During Therapy for Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of Sequential Outcomes. ( Athale, U; Barr, RD; Cranston, A; Farncombe, T; MacDonald, P; Virdee, M, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| MacDonald, P | 1 |
| Cranston, A | 1 |
| Virdee, M | 1 |
| Farncombe, T | 1 |
| Athale, U | 1 |
| Barr, RD | 3 |
| Amin, NL | 1 |
| James, RM | 1 |
| Phillips, R | 1 |
| Kotecha, RS | 1 |
| Powers, N | 1 |
| Lee, SJ | 1 |
| Murray, KJ | 1 |
| Carter, T | 1 |
| Cole, C | 1 |
| Wiernikowski, JT | 1 |
| Webber, C | 2 |
| Guo, CY | 1 |
| Wright, M | 1 |
| Atkinson, SA | 1 |
| Tragiannidis, A | 1 |
| Athanassiadou, F | 1 |
| Papageorgiou, T | 1 |
| Petsatodis, G | 1 |
| Lethaby, C | 1 |
| Wiernikowski, J | 1 |
| Sala, A | 1 |
| Naronha, M | 1 |
1 review available for alendronate and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
QUESTION 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia?
Topics: Adolescent; Alendronate; Antineoplastic Agents; Bone Density Conservation Agents; Diphosphonates; Fe | 2016 |
3 trials available for alendronate and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Alendronate; Antineoplastic Combined Chem | 2010 |
Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Topics: Absorptiometry, Photon; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Alendronate; Bone | 2005 |
Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience.
Topics: Adolescent; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; C | 2007 |
2 other studies available for alendronate and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Safety and Efficacy of Alendronate to Treat Osteopenia in Children During Therapy for Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of Sequential Outcomes.
Topics: Absorptiometry, Photon; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Diseases, | 2023 |
Severe skeletal complications in a child with acute lymphoblastic leukemia.
Topics: Alendronate; Bone Density; Child; Female; Femur Neck; Humans; Lumbar Vertebrae; Osteoporosis; Precur | 2006 |